Abortion Access
NEWS: Despite state bans, abortions nationwide are up, driven by telehealth

NEWS: Supreme Court skeptical of challenge to mifepristone

In the first abortion-related case before the Supreme Court since its 2022 decision to overturn Roe v. Wade, a majority of the justices appeared to express skepticism that a coalition of anti-abortion doctors had the right to challenge the Food and Drug Administration’s 2016 and 2021 decisions to expand access to mifepristone, a drug used for medication abortion.